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Abstract Serpins define a large protein family in which most
members function as serine protease inhibitors. Here we report
the results of a search for serpins in Drosophila melanogaster
that are potentially required for oogenesis or embryogenesis. We
cloned and sequenced ovarian cDNAs that encode six distinct
proteins having extensive sequence similarity to mammalian
serpins, including residues important in the serpin inhibition
mechanism. One of these new serpins in recombinant form
inactivates, and complexes with, trypsin-like proteases in vitro.
To our knowledge, these results represent the first evidence for a
serpin in Drosophila that functions as a serine protease inhibitor.
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1. Introduction
Serpins constitute a large family of proteins found in ani-
mals, plants, and viruses (for review see [1]). Most serpins
function as suicide substrate inhibitors of serine proteases.
Such inhibitory serpins, typically about 400 amino acids in
length, are cleaved by the target protease within a reactive
center loop region of about 20 amino acids near the C-termi-
nus. The amino acid N-terminal to the scissile bond (the P1
position) appears to be important for determining the specif-
icity of serpins for particular proteases. Further N-terminal
within the reactive center loop region are the residues of the
hinge region which are highly conserved among inhibitory
serpins. The hinge region appears to be mechanistically crit-
ical for the reactive center loop to undergo a dramatic con-
formational change upon serpin cleavage and for the forma-
tion of an essentially irreversible 1:1 complex of serpin and
protease.
Serpins are involved in diverse biological processes. Many
serpins found in human plasma regulate proteolytic reactions
important in blood coagulation, ¢brinolysis, the immune re-
sponse, and in£ammation. A serpin called maspin identi¢ed in
mammalian breast tissue has been implicated in tumor sup-
pression [2], whereas another serpin, PEDF, has been identi-
¢ed as a neurotrophic factor and as a regulator of angiogen-
esis [3,4]. PEDF is one example among several of a serpin that
does not function as a serine protease inhibitor. Such non-
inhibitory serpins may lack certain key residues, as in the
reactive center loop region, necessary for inhibitory activity
[1].
The genome of the fruit £y, Drosophila melanogaster, likely
contains many serpin genes (Berkeley Drosophila Genome
Project, unpublished). The ¢rst serpin from this organism to
be described was the Acp76A protein, a component of the
male accessory gland that is transferred to the female during
mating [5]. More recent studies have demonstrated a role for
another serpin in anti-fungal defense in Drosophila [6]. It has
not yet been biochemically demonstrated that either of these
serpins is active as a serine protease inhibitor.
We are interested in de¢ning a developmental role for ser-
pins using genetic analysis in Drosophila. A developmental
process in Drosophila that may involve serpins is dorsoventral
patterning of the embryo. Genetic studies have identi¢ed four
serine proteases required to generate a ventral signal that
initiates dorsoventral patterning, perhaps acting sequentially
in a cascade like the mammalian blood clotting proteases [7].
While there is no genetic evidence that a serpin is involved in
dorsoventral patterning, there is indirect biochemical evidence
that one of the serine proteases in the dorsoventral cascade
complexes with a serpin in the embryo [8].
Here we report the deduced sequences of six new Drosophila
serpins identi¢ed in a search for serpins that potentially func-
tion in oogenesis or embryogenesis, including dorsoventral
patterning. Sequence analysis suggests that the six serpins
are likely to function as serine protease inhibitors. As a ¢rst
step toward de¢ning a developmental role for these serpins as
serine protease inhibitors, we provide biochemical evidence
that one of these serpins is a potent inhibitor of trypsin-like
proteases in vitro.
2. Materials and methods
2.1. RT-PCR
We used standard methods for isolation and analysis of DNA and
RNA, including RT-PCR [9]. Ovaries of Oregon R strain £ies were
manually dissected [10], and total RNA was extracted from ovaries
with the Trizol reagent (Gibco-BRL, Gaithersburg, MD). Degenerate
oligonucleotides were designed that corresponded to two amino acid
sequences, NAVYFKG and DVNEEG, conserved between horseshoe
crab and human serpins [11]. PCR reaction (40 cycles of 94‡C 1 min,
50‡C 1 min, and 72‡C 1 min, followed by 72‡C 7 min) using these
oligonucleotides as primers yielded a 520 bp DNA fragment, which
was cloned into the TA vector (Invitrogen, Carlsbad, CA). DNA
sequencing of multiple clones of this fragment revealed that we had
isolated partial cDNAs potentially encoding four di¡erent proteins,
which by BLAST search of the GenBank database were found to be
homologous in sequence to previously characterized serpins. 5P and 3P
RACE reactions were performed to isolate full-length cDNAs, which
were sequenced in both strands to derive the sequences of four di¡er-
ent proteins (designated sp1^4). We subsequently found that sequen-
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ces matching sp1^4 are in four Drosophila EST clones (GH04125,
GH08778, GH09216, and GH08104) from an adult head cDNA li-
brary (Berkeley Drosophila Genome Project/HHMI EST project, un-
published). We also identi¢ed two additional Drosophila EST clones,
LD11594 and GM04155, from embryo and ovary cDNA libraries that
revealed partial sequences for two additional serpins, designated sp5
and sp6, respectively. These two EST clones were obtained and se-
quenced in both strands to derive the complete sequences of sp5 and
sp6 (5P RACE reaction was necessary to obtain DNA to complete the
sequence for sp5).
2.2. Chromosome and RNA in situ hybridization
In situ hybridization to salivary gland polytene chromosomes was
done essentially as described by Todd Laverty (http://www.fruit-
£y.org/methods/). RNA in situ hybridization to whole mounts of
ovaries and embryos was performed [12] using single-stranded RNA
probes labeled with digoxigenin (Roche, Indianapolis, IN).
2.3. Bacterial expression and a⁄nity puri¢cation of serpins
Standard PCR methods were used to clone into the plasmid pET-
21a (Novagen, Madison, WI) DNA encoding sp6 with six additional
histidines (His-tag) at both N- and C-termini [13]. The sp6 protein
was puri¢ed from 100 ml of BL21(DE3) pLysS cells (Novagen) by
a⁄nity chromatography on a Ni-NTA resin following the manufac-
turer’s protocol (Qiagen, Valencia, CA).
2.4. Protease inhibition and serpin^protease complex assays
To measure protease inhibition, protease at 10 nM was mixed with
puri¢ed sp6 (10^100 nM) in 20 mM Tris^HCl, pH 7.4; 100 mM
NaCl; 1 mg/ml PEG 8000 (TS/PEG bu¡er). After incubation at
room temperature for varying time periods, an aliquot (100 Wl) of
the reaction was withdrawn and rapidly mixed with an appropriate
chromogenic substrate solution (100 WM) in a cuvette. Protease activ-
ity was monitored at 405 nm in a spectrophotometer for 2 min. In the
reaction with trypsin, 20 mM CaCl2 was included in the TS/PEG
bu¡er and substrate solution. The proteases and their respective sub-
strates were: bovine pancreas trypsin and D-Phe-L-pipecolyl-Arg-
pNA, bovine pancreas chymotrypsin and N-succinyl-Ala-Ala-Pro-
Phe-pNA, human K-thrombin (Haematologic Technologies, Essex
Junction, VT) and tosyl-Gly-Pro-Arg-p-nitroanilide (Roche, Indian-
apolis, IN), porcine pancreas elastase and N-succinyl-Ala-Ala-Pro-
Leu-pNA, porcine blood plasmin and tosyl-Gly-Pro-Lys-pNA, and
porcine pancreas kallikrein and H-D-Phe-pipecolyl-Arg-p-nitroanilide
(Chromogenix AB, Mo«lndal, Sweden). Unless otherwise noted, pro-
teases and substrates were from Sigma (St. Louis, MO).
To measure serpin^protease complex formation, aliquots of the
Fig. 1. Primary structures of sp1^6. The complete amino acid sequences of sp1^6 and of the prototypical serpin human K1-proteinase inhibitor
(K1-PI) [21] were aligned using MEGALIGN software (DNASTAR Inc., Madison, WI). Residues matching the consensus are boxed. Residues
of the N-terminal signal sequences are in lowercase letters [22]. The underlined region is analyzed in Fig. 2. The accession numbers for sp1^6
are AJ251744^9, respectively.
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reaction containing protease and sp6 as described above were with-
drawn, mixed with SDS sample bu¡er, and immediately boiled for
5 min. Samples were analyzed by electrophoresis on SDS^PAGE
gels, which were stained with Coomassie blue.
2.5. Determination of second-order rate constant
The second-order rate constant for interaction between protease
and sp6 was determined by the discontinuous method under pseudo
¢rst-order conditions [14]. Protease inhibition was assayed as de-
scribed above using 100 nM of puri¢ed sp6. The pseudo ¢rst-order
rate constant (kobs) was obtained from the slope of a plot of ln[E]
versus time (t) according to the equation ln[E]t = ln[E]03kobst, in
which [E]t and [E]0 are protease activity at time t and time zero,
respectively. The second-order rate constant (k) was determined
with the equation k = kobs/[I]0, where [I]0 is the initial sp6 concentra-
tion.
3. Results and discussion
3.1. Analysis of cDNAs encoding Drosophila serpins
At the time we began our studies, the male accessory gland
protein Acp76a was the only serpin in D. melanogaster that
had been identi¢ed. To identify additional serpins in this or-
ganism, we used a RT-PCR strategy (see Section 2). We used
ovarian RNA as the template in the RT-PCR reaction to bias
our search for serpins that could be candidate regulators of
the serine proteases involved in dorsoventral patterning and
that therefore would be maternally expressed like these pro-
teases [7]. Using this strategy, we cloned cDNAs encoding
four distinct polypeptide sequences similar to sequences of
serpins from other organisms, as revealed by BLAST search
of the GenBank database. In addition, we identi¢ed two Dro-
sophila EST clones encoding two additional serpin-like se-
quences (see Section 2). The proteins potentially encoded by
the di¡erent cDNAs were designated sp1^6. By in situ hybrid-
ization analysis, we mapped DNA encoding sp1, sp4, and sp5
to chromosomal locations 42E1^2, 42D1^5, and 88E3^5, re-
spectively (data not shown). Although we did not map the
chromosomal location of DNA encoding sp2, sp3, or sp6,
ESTs matching the sequences for sp2 and sp6 exist within
P1 clones that roughly map to 28E^29A and 55A^B, respec-
tively (Berkeley Drosophila Genome Project, unpublished).
Full-length cDNAs were sequenced to derive the complete primary structure of sp1^6, which range in length from 372 to
427 amino acids (Fig. 1). The level of sequence identity be-
tween any two proteins is 21^70%, with sp2 and sp3 most
similar to each other and sp5 the most di¡erent from the
others. Four of the proteins, excluding sp4 and sp6, are pre-
dicted to have a signal sequence at the N-terminus (Fig. 1).
BLAST search of the GenBank database revealed that all
six proteins are new members of the serpin family, having
sequence identity from 20 to 40% with serpins from mammals
and other organisms (a comparison with K1-proteinase inhib-
itor is shown in Fig. 1). The closest homologue for sp4 ap-
pears to be human neuroserpin [15], whereas sp1, sp2, sp3, sp5
and sp6 appear to be most similar in sequence to members of
the ov-serpin sub-family, which includes inhibitory serpins
such as human plasminogen activator inhibitor-2 and non-
inhibitory serpins such as chicken ovalbumin [16]. Despite
this similarity, the ¢ve Drosophila serpins may belong in a
distinct group, as they do not share all characteristics of ov-
serpins. For example, in contrast to the case with ov-serpins,
sp1, 2, 3, and 5 have a recognizable signal sequence at the N-
terminus, as mentioned above (Fig. 1). In addition, sp6 is
encoded in two exons, a di¡erent pattern than the seven-
Fig. 2. Predicted reactive center loop regions of sp1^6. C-terminal
regions of sp1^6 (underlined in Fig. 1) were compared with the re-
active center loop regions of human K1-PI, human antithrombin
(AT) [23], human neutrophil elastase inhibitor (HNEI) [24], and
mouse squamous cell carcinoma antigen-2 (SCCA-2) [25]. Boldface
lettering highlights the hinge region important for the serpin inhibi-
tion mechanism as well as the residues (P1 and P1P) £anking the
scissile bond [26]. A ¢xed distance between hinge region and P1 res-
idue and the common occurrence of serine as the P1P residue in in-
hibitory serpins were used as criteria to predict the reactive site of
sp1^6 [1].
Fig. 3. Expression of sp2 RNA during oogenesis and embryogenesis.
RNA in situ hybridization analysis of whole mount ovaries and em-
bryos using RNA probes corresponding to the sense and antisense
strands of sp2. A: During oogenesis, the oocyte (oo) develops with-
in the egg chamber, which also contains 15 nurse cells (nc) and an
epithelium of follicle cells surrounding the oocyte and nurse cells
[17]. The dashed line roughly marks the oocyte border with nurse
and follicle cells. The labeled egg chamber is at a stage just prior to
the time when materials necessary for early embryogenesis are trans-
ferred from the nurse cells to the oocyte. Smaller egg chambers at
earlier stages are visible to the left. These egg chambers were incu-
bated with the sp2 sense probe to serve as a control for non-speci¢c
hybridization. B: Egg chambers at a similar stage as the labeled egg
chamber in A show an intense hybridization signal in nurse cells
when incubated with the sp2 antisense probe. Hybridization signal
is also visible in younger egg chambers to the left. C: Example of a
late-stage embryo incubated with the sp2 antisense probe showing
intense hybridization signal in multiple tissues, including the nerve
cord which runs along the curved ventral side of embryo toward
the bottom of the ¢gure.
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exon structure of ov-serpin genes [1] (J.-H. Han, unpublished
observation).
The C-terminal regions of sp1^6 can be aligned with the
reactive center loop regions of serpins known to be active as
serine protease inhibitors (Fig. 2). This alignment shows that
sp1^6 all contain highly conserved residues of the hinge region
important for the serpin inhibition mechanism, suggesting
that they are likely to be active as serine protease inhibitors
[1]. This alignment also predicts that the reactive site residue
at the P1 position is a leucine for sp2 and either an arginine or
a lysine for sp1 and sp3^6. Thus, as a serine protease inhib-
itor, sp2 should be active against a chymotrypsin-like pro-
tease, whereas the others would be active against trypsin-
like enzymes.
3.2. Expression patterns of the Drosophila serpins
Although we cloned cDNAs for sp1^4 from ovarian RNA,
we wanted to con¢rm that the RNAs encoding these serpins
are expressed in the ovary. In addition, we wanted to know
what cell type in the ovary expressed these serpins. By RNA
in situ hybridization analysis, we found that RNAs encoding
these four serpins are expressed predominantly in the nurse
cells, which are principally responsible for providing the oo-
cyte with materials necessary for early embryogenesis [17].
While expression of all four serpins was detected throughout
the early stages of oogenesis, it appeared to peak during
stages 9^10, just prior to the time when there is a major trans-
fer of materials from the nurse cells to the oocyte (illustrated
for sp2 in Fig. 3A,B). We detected comparably little expres-
sion of these serpins in the follicle cells that secrete eggshell
components around the oocyte. The expression of sp1^4 in
ovarian nurse cells is compatible with a role for these serpins
in oogenesis or embryogenesis.
Two types of observations suggest that sp1^4 function at
other developmental stages and in other tissues. First, by
RNA in situ hybridization, we detected sp1^4 transcripts
throughout embryogenesis in a variety of di¡erent tissues (il-
lustrated for sp2 in Fig. 3C). Second, the sequences of sp1^4
are represented in EST clones isolated from an adult head
cDNA library (see Section 2).
The genes encoding sp5 and sp6 also appear to have com-
plex expression patterns that include the ovary. While an EST
clone for sp5 was isolated from an embryonic cDNA library
(see Section 2), we also detected sp5 transcripts in the ovary
by RT-PCR analysis (data not shown). In addition, the se-
quence of sp6 is found in EST clones from both larval/pupal
and ovarian cDNA libraries (see Section 2).
3.3. Inhibition of serine proteases by recombinant serpin sp6
To test whether sp1^6 function as serine protease inhibitors
in vitro, we wanted to make recombinant forms of these pro-
teins. Of the serpins that were expressed with a His-tag in
bacteria (see Section 2), only sp6 could be obtained in a prep-
aration of su⁄cient purity and quantity necessary for bio-
chemical studies (see Fig. 5, lane 9). To assay for inhibition,
we incubated increasing amounts of recombinant sp6 with
various serine proteases and measured the hydrolysis of syn-
thetic chromogenic substrates by the proteases (see Section 2).
Using this assay, we found that recombinant sp6 e⁄ciently
inhibited the activities of elastase, plasmin, thrombin, and
trypsin (illustrated for trypsin in Fig. 4A,B).
To obtain a quantitative measure of inhibitory activity, we
calculated the second-order rate constants for interaction be-
tween sp6 and proteases (see Table 1). By this criterion, re-
combinant sp6 inhibited trypsin about 30 times more than K1-
proteinase inhibitor, and inhibited thrombin, a trypsin-like
enzyme, as e⁄ciently as antithrombin (in the absence of hep-
arin). These results demonstrate that sp6 is a potent serine
protease inhibitor. However, sp6 appeared to be weakest as
an inhibitor against elastase. In addition, sp6 was inactive
towards chymotrypsin and appeared to be cleaved by chymo-
trypsin (data not shown). This speci¢city suggests that the
natural target of sp6 is a trypsin-like serine protease, consis-
Fig. 4. Recombinant sp6 inhibits trypsin. A: Inhibition of trypsin by increasing amounts of sp6. The change in absorbance at 405 nm due to
hydrolysis of a chromogenic substrate by trypsin was measured over a 2 min period after prior incubation of trypsin with sp6, as described in
Section 2. Essentially complete inhibition is observed at 100 nM sp6. B: Time course of trypsin inhibition by sp6. Trypsin activity was mea-
sured as above after prior incubation of trypsin without (open circle) or with (closed circle) 100 nM sp6 for the time periods indicated. Fitted
curves were generated using UltraFit software (Biosoft, Ferguson, MO).
Table 1
Second-order rate constants for interaction between protease and
serpin (M31 min31)
sp6a K1-PIb Antithrombinc;d Antithrombin+
heparinc;d
Trypsin 2.6U107 7.8U105 9.0U106c 6.6U107c
Thrombin 1.4U106 ^ 5.3U105d 2.2U109d
Elastase 5.3U104 3.9U109 ^ ^
aRate constants were determined as described in Section 2.
bData are from [18].
cData are from [19].
dData are from [20].
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tent with an arginine as its predicted reactive site P1 residue
(see Fig. 2).
3.4. SDS-stable complexes of recombinant sp6 with serine
proteases
A hallmark of the serpin inhibition mechanism is the for-
mation of a stable complex of serpin and protease that cannot
be dissociated by boiling in SDS [1]. To determine whether
recombinant sp6 could form such a complex with its target
proteases identi¢ed above, we incubated sp6 with protease
and analyzed complex formation by SDS^PAGE (see Section
2). As shown in Fig. 5, incubation of sp6 with trypsin resulted
in a polypeptide band of about 67 kDa (lane 1) which matches
the predicted size of a complex composed of trypsin (25 kDa)
and sp6 (42 kDa). By the same criterion, sp6 appeared to
form a complex with plasmin (lane 3), elastase (lane 5), and
thrombin (lane 7). Taken together with the protease inhibition
data described above, the results of these experiments demon-
strate that sp6 is a serine protease inhibitor.
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Fig. 5. Recombinant sp6 forms stable complexes with serine pro-
teases. Complex formation between recombinant sp6 and various
proteases was analyzed by SDS^PAGE as described in Section 2.
Co-incubation of puri¢ed sp6 with trypsin, plasmin, elastase, or
thrombin produced a band in the 70^80 kDa range (marked with
an asterisk; lanes 1, 3, 5, and 7) matching the predicted size of a
1:1 complex of serpin and protease (molecular weight markers in
kDa are shown on the left). This band was not seen in the sample
of each protease (lanes 2, 4, 6, and 8) or sp6 (lane 9) alone. The
presence of multiple bands between the putative sp6^elastase com-
plex and free sp6 may be due to degradation of the complex, per-
haps by a trace amount of free elastase. Trypsin, plasmin, and elas-
tase migrated with the dye front and therefore are not visible,
whereas thrombin is visible as a band of 37 kDa in lane 8. The
bands visible in lane 4 likely represent contaminants in the plasmin
sample.
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